Related Experiment Video
Updated: Jun 4, 2026
09:41
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
New developments in conditioning regimens before auto-SCT in multiple myeloma
P Moreau1, M Attal, J L Harousseau
1Hematology Department, University Hospital Hôtel-Dieu, Nantes, France. philippe.moreau@chu-nantes.fr
Bone Marrow Transplantation
|March 2, 2011
Abstract:
The current standard conditioning regimen before auto-SCT in patients with multiple myeloma is melphalan 200 mg/m(2). Several attempts have recently been made to improve this aspect of the high-dose therapy procedure. The scope of this review article is to summarize current knowledge on conditioning regimens in this setting.
